Table 1. Male IPF (A group), non‐CF bronchiectasis (B group), or asthma (C group) urine-derived exosomes (Age of subject at collection).

Subject number	Age of subject at collection	Ethnicity	FEV1 (liters)	FVC (liters)	FEV/FVC (%)	FEV/FVC(predicted)	DLCO (% reference)
A4	72	Caucasian	2.93	3.75	78	77	11.8 (47)
A6	79	Caucasian	2.36	2.91	81	67	16.2 (101)
A26	69	Hispanic	1.67	1.98	84	72	NT
A35	69	Hispanic	1.71	2.22	70	73	NT
A37	69	Hispanic	2.7	3.21	84	77	10.5 (44)
A62	67	Hispanic	1.94	2.33	82	77	8.7 (33)
A74	75	Hispanic	2.48	2.77	80	74	9.9 (49)
A77	55	Hispanic	1.14	1.27	90	78	6.7 (32)
A80	70	Caucasian	2.09	2.62	78.9	87.49	11.8 (48)
A83	68	Hispanic	2.39	2.69	86	75	10.5 (49)
A84	67	Caucasian	1.78	2.12	84	84	14.1 (57)
A88	66	Hispanic	1.36	1.39	98	75	2.6 (11)
A90	67	Caucasian	2.48	2.85	88.9	74	12.8 (45)
A103	72	Hispanic	1.95	2.64	74	75	13.4 (59)
A104	76	Caucasian	2.95	3.27	90	65	14.6 (58)
A105	62	Hispanic	1.47	1.69	87	78	11.7 (41)
B1	73	Caucasian	1.04	2.06	50	79.91	9.6 (48)
B10	70	Hispanic	1.33	2.89	46	74	21.29 (69.5)
B13	86	Hispanic	2.54	3.59	70.7	74	23.08 (76.78)
C1	36	Hispanic	3.67	4.75	77.16	82.89	31.49 (92)
C4	61	Caucasian	3.38	4.72	71.65	79.09	27.77 (96)
C7	44	Caucasian	3.08	4.57	67.3	70	27.83 (96)

NT, not tested.